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Abstract
Purpose: A comparative treatment planning study has been undertaken between standard photon delivery techniques,b intensity modu-
lated photon methods and spot scanned protons in order to investigate the merits and limitations of each of these treatment approaches.
Methods: Plans for each modality were performed using CT scans and planning information for nine patients with varying indications and
lesion sites and the results have been analysed using a variety of dose and volume based parameters.
Results: Over all cases, it is predicted that the use of protons could lead to a reduction of the total integral dose by a factor three compared
to standard photon techniques and a factor two compared to IM photon plans. In addition, in all but one Organ at Risk (OAR) for one case,
protons are predicted to reduce both mean OAR dose and the irradiated volume at the 50% mean target dose level compared to both photon
methods. However, when considering the volume of an OAR irradiated to 70% or more of the target dose, little difference could be shown
between proton and intensity modulated photon plans. On comparing the magnitude of dose hot spots in OARs resulting from the proton and
IM photon plans, more variation was observed, and the ranking of the plans was then found to be case and OAR dependent.
Conclusions: The use of protons has been found to reduce the medium to low dose load (below about 70% of the target dose) to OARs and
all non-target tissues compared to both standard and inversely planned photons, but that the use of intensity modulated photons can result in
similar levels of high dose conformation to that afforded by protons. However, the introduction of inverse planning methods for protons is
necessary before general conclusions on the relative ef®cacy of photons and protons can be drawn. q 1999 Elsevier Science Ireland Ltd. All
rights reserved.
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1. Introduction
Since the widespread introduction of computer tomo-
graphic (CT) scanners and other three-dimensional (3D)
imaging modalities, treatment planning has become an
increasingly important aspect of radiotherapy. In many
ways, progress in planning technology has run in parallel
with, and in some cases has been the driving force behind,
many of the advances in delivery hardware that are now
entering clinical use. These advances mainly have the aim
of improving delivery methods such that the high dose
volume approaches the volume of the clinical target, thus
reducing unnecessary dosage to healthy tissues. Such highly
conformal methods are now gaining acceptance in the clin-
ical environment and in the near future are likely to become
the routine treatment method for many indications.
Many of the proposed methods for improved localisation
of the high dose volume centre either on the use of sophis-
ticated planning and delivery methods and/or on the use
of radiations which show improved dose localisation char-
acteristics. In mega-voltage X-ray therapy, the use of asym-
metric and dynamic wedges, irregularly shaped ®elds (i.e.
using customised blocks or multi-leaf collimators) and
the delivery of non-uniform intensity pro®les of the incident
radiation using compensators have all contributed to
reducing the treated volume. In parallel with these develop-
ments, treatment planning systems have become corre-
spondingly more elaborate, providing the radiation oncol-
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ogist with many options for conforming the dose in three
dimensions.
With the number of degrees of freedom now available in
the planning of radiation therapy, it is perhaps inevitable
that great interest is being shown in the optimisation of
treatment plans. In recent years, such techniques have
been used in the calculation of beam weights [30,35], for
determination of wedge angles using dynamic wedges [42]
or for the selection of beam directions [5,16]. However,
perhaps the most promising of the optimisation techniques
are that group which aim to modulate the cross-®eld ¯uence
of the applied beams [4,17,20,38,39,50].
One of the early attempts at reducing treatment volumes
came with the use of protons in radiotherapy, as proposed by
Wilson [51]. Wilson recognised the clear physical advan-
tage of the proton depth-dose characteristic over that of a
photon beam, and this was used as the rationale to treat
patients with protons beginning around the early 1960s.
By the end of 1997, over 24 000 patients had been treated
using protons at 21 sites world-wide, the majority at Massa-
chusetts General Hospital using the original Harvard Cyclo-
tron [44]. For the treatment of deep seated tumours with
protons, all the currently operational facilities use the so
called passive scattering method [3,22,23] that was ®rst
developed at the Harvard Cyclotron. More recently,
however, some groups have proposed the use of scanned
particle beams for dynamic delivery [21,40], which can
both improve dose conformation [48] and has the potential
to deliver non-uniform ®elds in three-dimensions [9,28].
A body of literature predicts that the use of protons in
some cases can provide considerable improvements in dose
conformation when compared to conventional X-ray deliv-
ery methods [24,31±34,45±47]. Such comparative treatment
planning studies have commonly been used as a method of
evaluating different treatment techniques and modalities
(see, e.g. [15,19,36]) as well as in evaluating the usefulness
of intensity modulated X-ray therapy in comparison with
standard planning techniques and between different optimi-
sation regimes [49]. We have previously reported on the
results of a treatment planning intercomparison between
protons and intensity modulated photons in a single case
of childhood Medulloblastoma [34]. However, to date,
detailed comparisons of proton therapy with state-of-the-
art intensity modulated X-ray techniques in a number of
different sites and indications have not been performed.
Here we present the results of a three-way treatment plan-
ning inter-comparison between standard photons, intensity
modulated photons and protons as applied to a total of nine
cases of varying indication and anatomical site.
2. Materials and methods
2.1. Data collection and exchange
Three centres have been involved in the study: the Paul
Scherrer Institute (PSI); the University Hospital of
Lausanne (CHUV) in Switzerland and the German Cancer
Research Centre (DKFZ) in Heidelberg. Each centre
provided three cases for evaluation, listed in full with
their indications in Table 1. The conversion of planning
data between the different planning systems was performed
at PSI and all data transfers were made using FTP over
internet connections. Volumes of interest (VOIs) were
de®ned at the originating institute and both the CT and
VOI ®les were distributed to the various centres for plan-
ning. All CT data were volumetric, with a maximum slice
separation of 5 mm, and VOIs were de®ned in 3D on all the
relevant slices. For the sake of simplicity, the target volumes
were, in all cases, assumed to include a safety margin, and
were thus considered to be planning target volumes as
de®ned in ICRU 50 [18]. Three dimensional dose distribu-
tions were calculated by each of the planning systems and
were collected for evaluation at PSI using an in-house
developed plan comparison package [26].
2.2. Planning methods
All standard photon plans were provided by either
CHUV, using the DOSIGRAY planning system, or were
planned using the VOXELPLAN system at either DKFZ
or PSI [1,2]. By routinely available, we refer to the use of
a limited number of beam ports, each of which can be indi-
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Table 1
List of all the cases, their indications and plan descriptionsa
Case number Indication Photons IMRT photons Protons
1 Meningioma LL,RL,LPO 9 ®elds RL,S
2 Malignant melanoma A,LPO,RAO 9 ®elds A,RL
3 Klatskin tumour LL,RAO,RPO 9 ®elds RAO
4 Metastasising prostate carcinoma A,LL,RL 9 ®elds A
5 Cervix cancer LAO,RAO,LPO,RPO 9 ®elds 2 £ RAO,RPO
6 Chromophobic pituitary adenoma RL,LL,SPO 9 ®elds LL,LAO,SALO
7 Simulated thyroid carcinoma A,RL,LL 9 ®elds LAO,RAO
8 Acinus cellcarcinoma - 9 ®elds A,LL
9 Relapsing medulloblastoma - 9 ®elds P,LAO,LPO,RAO
a For the photon and proton plans, the following nomenclature to describe ®eld incidences has been adopted: L, lateral; O, oblique; L, left; R, right; A,
anterior; P, posterior; S, superior.
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Fig. 1(a).
vidually shaped but for which the beam intensity is ®xed or
is modi®ed only by the use of ®xed or dynamic wedges.
Intensity modulated photon treatment plans were optimised
using a forerunner of the KonRad inverse planning program
developed at DKFZ [4,8,41] which has been investigated
dosimetrically [7] and is currently in clinical use at
DKFZ, and, in a modi®ed form, at the Memorial Sloan
Kettering Cancer Centre [25]. It is based on an iterative
steepest descent optimisation technique, which considers
prescribed minimum and maximum dose constraints in the
target as well as upper dose limits in organs at risk. DVHs
constraints can also be de®ned [8], but this capability has
not been used for the present investigation. In addition, so-
called penalties are used to control the relative importance
of these constraints. The dose is calculated using a simpli-
®ed pencil beam algorithm in which the photon scatter
kernel is assumed to be invariant with depth (using a simpli-
®ed version of the technique described by Bortfeld [6]).
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Fig. 1. (a) Central slices from each plan for cases 1±5. (b) Central slices from each plan for cases 6±9. Dose levels are as indicated in the colour bars on the right
hand side of each image. Note, for cases 8 and 9, no standard photon plans were performed.
Tissue inhomogeneities can be considered through one-
dimensional path length correction, but they are ignored in
the present study, which uses an older implementation of the
code. Although the inclusion of heterogeneity corrections
would certainly alter the resultant IM matrices, we have
assumed that the optimisation process would mostly
compensate for these effects and we don't expect that the
dose distributions would vary signi®cantly from those
presented in this paper. For all the cases studied here, IM
photon plans were calculated using nine evenly spaced ®eld
directions (see Table 1).
All proton plans presented in this paper have been calcu-
lated using a treatment planning system developed at PSI
speci®cally for the delivery of proton therapy using spot
scanning [27,40,43]. Although the clinical advantages of
this method over the more widespread passive scattering
approach are a matter of debate [14,48], it nevertheless
provides the most ¯exible method of particle delivery for
conforming the dose in all three dimensions. Dose calcula-
tions are performed by taking into consideration all those
Bragg peaks, deposited on a 5 mm matrix, which are inside
or within 5 mm of the surface of the planning target volume.
The relative weights of all these peaks are then calculated
using a least squared minimisation technique [27].
However, in contrast to the photon technique, the optimisa-
tion for all the proton plans presented here have been
performed for individual ®eld directions only and with the
single criteria of producing a relatively homogenous (^5±
10%) dose across the target volume. Critical organs are
ignored by the optimisation process and multiple ®eld
dose distributions were formed by the simple addition of
the individually optimised ®elds. Thus, although optimised,
the proton plans presented here are not IM plans in the
commonly accepted sense of that term, and can more accu-
rately be described as having been planned using conven-
tional, forward planning techniques. For all the proton dose
calculations, in-homogeneities along the beam direction
were taken into account and lateral spread was modelled
taking into account the effects of the initial phase space of
the beam, nozzle-to-patient air gaps and multiple coulomb
scattering within the patient.
3. Results
Example slices for each case are shown in Fig. 1a (cases
1±5) and Fig. 1b (cases 6±9). For each case, the standard
photon plan is shown on the left, the intensity modulated
photon plan in the middle and the proton plan on the right.
Descriptions of each plan for each case are shown in Table
1, and the normal tissue constraints of individual OARs used
by the IM photon optimisation are shown in Table 4. Note
that for cases 8, 9, no standard photon plans have been
performed. In all cases, the dose distributions have been
normalised to the mean target dose delivered by each
plan, and the doses have been coded using the colour band-
ing indicated to the right hand side of each image. The
banding levels (as a percentage of the normalisation dose)
indicate the transition level from one colour band to the next
and in all cases have been equally spaced between 30 and
90% of the normalisation dose. The maximum displayed
dose value indicates the maximum dose anywhere within
the distribution.
In this section, we will ®rst present a dosimetric summary
of all the cases, in the form of target coverage, integral dose
estimates and doses to organs at risk (OAR) and follow this
with more detailed studies of four cases of particular inter-
est.
3.1. General results
3.1.1. Target coverage and non-target tissue doses
Tables 2 and 3 summarise some general results of the
planning inter-comparisons. As a measure of the target
coverage achieved by each planning method, we have calcu-
lated the minimum signi®cant dose that the target receives
from each plan. Within the target volume, we de®ne this to
be the maximum dose level for which a connected region, of
de®ned volume, exists within which all dose grid points are
irradiated to this dose level or below. Thus, minimum
signi®cant dose provides a measure of the magnitude of a
cold spot of signi®cant size within the target volume [11]. In
this work, the de®ned volume has been taken to be equiva-
lent to the volume of a sphere of radius 0.75 cm (the ICRU
de®nition of a hot spot in an OAR [18]).
From the cold spot analysis shown in Table 2 it can be
seen that the proton plans generally provide good coverage
of the target, with only one proton plan predicting a cold
spot lower than 95% (case 5 with a minimum signi®cant
dose of 93%). For both the standard and IM photon plans,
the results vary somewhat, with three standard photon plans
(worst case 59% cold spot for case 2) and ®ve IM photon
plans (worst case 77% for case 7) having cold spots of less
than 95%.
Table 3 provides estimates of the volume of non-target
tissue irradiated to a dose level of 30% or more, which we
use as a surrogate of the integral dose in order to summar-
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Table 2
Minimum signi®cant doses to the targets of each case as a percentage of the
mean target dose (for full description, see text)
Minimum signi®cant dose in target (%)
Case Proton Photon IM
1 96 100 91
2 96 59 87
3 95 97 97
4 96 77 93
5 93 95 81
6 98 97 97
7 94 76 77
8 96 ± 87
9 95 ± 93
ise the dose delivered to all non-target tissues. In all cases,
the photon and intensity modulated plans predict that a
higher volume of normal tissue will be irradiated to the
30% dose level than for the corresponding proton plan,
with this volume being 1.2±4.8 times higher for the stan-
dard photon plans and 1.0±4.5 times higher for the inten-
sity modulated plans. The mean ratios over all cases for
non-target tissue irradiation at the 30% level are 3.5 for the
photon plans and 2.1 for the intensity modulated plans
(Table 3).
3.1.2. Organ at risk (OAR) doses
The predicted doses to all organs at risk for all the cases are
summarised in Figs. 2 and 3. Fig. 2A,B shows, respectively,
the difference in the mean dose predicted for each OAR of
each case between the proton plan and the corresponding
standard photon plan (denoted as Dmean(OAR,P1) 2 Dmean
(OAR,X)) and the intensity modulated photon plan (denoted
as Dmean (OAR,P1) 2 Dmean (OAR,IMX)). The individual
OARs of each case are identi®ed numerically according to
the assignments given in Table 4. As the differences between
the proton and either photon plan is plotted, a dosimetric
advantage in a particular OAR for the proton plan appears
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Table 3
The volume (in cm3) of non-target tissue that would receive .30% of the
prescribed dosea
Volume (cm3) receiving .30% prescribed dose
Case Proton Photon IM
1 216 847 (3.9) 369 (1.7)
2 849 3348 (3.9) 3845 (4.5)
3 324 1567 (4.8) 593 (1.8)
4 2387 7759 (3.2) 6765 (2.8)
5 1563 4403 (2.8) 3374 (2.2)
6 366 1010 (2.8) 775 (2.1)
7 1039 3475 (3.3) 2090 (2.0)
8 792 ± 977 (1.2)
9 101 ± 100 (1.0)
Mean ± 3.5 2.1
a For the photon and intensity modulated plans, the volumes relative to
the proton plans are shown in brackets. Over all cases, the mean 30%
volumes relative to the proton plans are shown in the last row.
Fig. 2. Differences between proton plans and standard (A,C) and intensity modulated (B,D) plans for mean (Dmean) and maximum signi®cant dose (Dsig),
respectively.
as a point below the zero line, whilst a positive value indi-
cates a dosimetric advantage for one or other of the photon
plans. In both plots, the change in mean dose is expressed as a
percentage of the mean target dose.
From Fig. 2A,B, it can be seen that in all but one OAR of
one case, it is predicted that the use of protons would reduce
the mean dose by up to 80 percentage points in comparison
to standard photon planning techniques and by up to 50
percentage points compared to the intensity modulated
plans. In only one OAR of one case (the brain stem for
case 8) is the mean dose reduced through the use of intensity
modulated photons. This particular case is studied in more
detail below.
The mean dose to which an OAR is irradiated is propor-
tional to the integral dose delivered to that organ. As such,
this measure may only have direct relevance to organs that
can be considered to have a parallel (or near parallel)
architecture. As a measure of `hot spot' doses in the
OARs, we have plotted in Fig. 2C,D the difference in
maximum signi®cant dose (Dsig(OAR)) between the proton
plan and either photon plan for each OAR. This concept is
exactly analogous to the cold spot (minimum signi®cant
dose) analysis described above [11]. For OAR hot spot
analysis, a volume equivalent to a sphere of radius 0.75
cm [18] or 5% of the OAR volume, whichever is the smal-
lest, has been adopted.
As with the mean dose analysis, for no case are there any
OARs with a reduced Dsig resulting from standard photon
planning in comparison with the proton plan. When
compared to the IM photon plan, 27 of the 38 OARs
(70%) assessed over all the cases have reduced hot spot
intensity through the use of protons, whereas in eight of
the nine cases, the reverse is true, with the IM photon
plans exhibiting reduced hot spot intensity in at least one
OAR. Of these, cases 5,6,7,8 each have OARs for which the
Dsig is reduced by more than 10% of the mean target dose in
comparison with the proton plan. These cases will be
studied in more detail below.
Although useful parameters for quantifying integral dose
and hot spot intensity for individual OARs, both the mean
and maximum signi®cant dose provide little indication of
the dose-volume characteristics contained in the dose
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Fig. 3. Differences between proton plans and both standard (A,C) and intensity modulated (B,D) plans for the volumes of OARs irradiated to 50% or more (V50)
and 70% or more (V70), respectively.
volume histograms (DVHs). In order to somewhat charac-
terise the DVHs of the individual OARs, we have also
plotted the volumes of each OAR that would receive 70%
(V70(OAR)) and 50% (V50(OAR)) of the mean target dose. In
Fig. 3, these results have been plotted in a similar fashion to
Fig. 2. In all plots of Fig. 3, the difference in volume is
expressed as a percentage of the total volume of each OAR.
At the 70% dose level, the higher dose conformity result-
ing from the use of protons compared to standard photon
techniques is clearly demonstrated (Fig. 3A). In only one
case are the volumes of all OARs receiving 70% dose or
more comparable (case 3), whilst for all other cases, the
proton plans reduce V70 in the majority of OARs by as
much as 80% of the OAR volume (e.g. brain stem and
femur in cases 1,2 respectively). At the 50% dose level,
the pattern is similar, with a generally larger improvement
through the use of protons, particularly in case 2, where V50
is reduced by over 90% of the total volume in two OARs
(acetabulum and femur).
In contrast to the results for the standard photon plans,
when comparing protons with IM photons, no general
improvement at the 70% dose level is evident. The differ-
ences between the plans are generally much less, and,
although the majority of OARs have a reduced V70 with
protons, in four cases (4,5,7,8), some OARs show a reduc-
tion in V70 by as much as 40% for the IM photon plan (Fig.
3B). At the 50% dose level, the same comparison produces
results similar to those for the standard photon plans, with a
reduction of V50 for the majority of OARs through the use of
protons and only one OAR of one case showing a dosimetric
advantage for the IM photon plan (the brain stem in case 8).
3.2. Selected case studies
In Figs. 2 and 3, we have attempted to summarise both
doses and irradiated volumes of OARs such that the reader
can have an overview of the characteristics of the different
planning methods when applied to very disparate cases.
However, to gauge fully the real clinical relevance of
doses to particular OARs, a more detailed analysis is essen-
tial. In this section, we have selected four cases of particular
interest to be studied in more detail.
3.2.1. Case two
The ®rst case we discuss in detail is of a 64-year-old
female with a malignant melanoma in the right lumbar
region. The target volume is located in a super®cial location
anterior to the bladder and right femoral head (Fig. 1a) and
extends in the long axis from the upper pelvis to a third of
the way down the right thigh. The calculated volume of the
target is just under 1 liter (920 ccm) and the prescribed dose
was 66.6 Gy. DVHs for all de®ned VOIs are shown in Fig. 4.
For the anatomical VOIs, where necessary, the DVHs has
been calculated with those parts of the target volume that
partially overlap with the VOI removed.
All the DVHs for this case show a clear and substantial
separation between the proton plan and either of the stan-
dard or intensity modulated photon plans, indicating a
signi®cant dosimetric advantage in the use of protons for
all aspects of this case. In particular, the DVHs for the
outline, represents the dose±volume characteristics for all
the non-target tissues and graphically shows the four fold
reduction of the volume of normal tissue irradiated to 30%
(20 Gy) or more by the proton plan (already indicated in
Table 2). For the OARs, the use of protons in this case could
result in a drop of up to 30 Gy (45%) in the mean dose to the
acetabulum compared to the intensity modulated plan, as
well as reductions in ICRU hot spot intensity of up to 23
Gy (35%) in the case of the vagina. However, at about the
70% dose level (46 Gy) and above the irradiated volumes
are similar for both the proton and IM photon plans.
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Table 4
Numerical identi®ers of all OARs of all cases plotted in Figs. 2 and 3,
together with the corresponding tolerance doses used for the IM photon
plansa
Case number Oar number Oar description Tolerance dose (%)
1 1 Right eye 20
2 Left eye 20
3 Brain stem/pons 70
4 Whole brain
5 Left optic nerve
6 Right optic nerve
2 1 Bladder 65






3 1 Spinal cord 55
2 Right kidney 35
3 Left kidney 35
4 Liver
4 1 Right kidney 20






5 1 Rectum 65
2 Bladder 85
3 Large bowel 85
4 Total pelvis
6 1 Brain
2 Brain stem 60
3 Right eye 10
4 Right optic nerve 65
7 1 Spinal cord 10
2 Right lung 10
3 Left lung 10
8 1 Brain stem 40
2 Posterior fossa
9 1 Brain stem 60
a The tolerance doses are expressed as a percentage of the mean target
dose.
3.2.2. Case ®ve
This case is of a cervix carcinoma in a patient previously
treated with three cycles of chemotherapy. The target volume
is situated close to the bladder and rectum with both struc-
tures impressing into the de®ned target. As well as the target
volume, VOIs of the rectum, bladder, portions of the small
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Fig. 4. Note, proton DVHs are not visible for the rectum and vagina as this plan deposits no dose in either of these organs.
bowel and the whole pelvic region have been de®ned. DVHs
of all these structures are shown in Fig. 5.
For the target DVHs in Fig. 5, it can be seen that the IM
photon plan has a shallower shoulder than either of the other
plans, indicating some compromising of the target dose by
this modality. In nearly all the OAR DVHs, a clear separa-
tion between the proton and photon (both standard and IM)
plans are seen. However, perhaps the most interesting
feature of this set of DVHs is the overlapping of the proton
and IM DVH curves above the 60% level for the rectum,
indicating an improved high dose sparing of this organ by
the IM photon plan. This overlapping is also seen in Fig. 3B
as the single OAR appearing above the zero line for case 5.
In Fig. 6, the proton and IM photon dose distribution are
shown zoomed in the region of the target±rectum border.
This ®gure clearly shows that in order to reduce the maxi-
mum dose to the rectum, the intensity modulated plan, has
in fact, compromised the dose to the target in the immediate
vicinity of the rectal surface, such as to reduce the maximum
dose to that organ. This dose gradient is re¯ected in the
larger volume of target under dosage seen in Table 2
(81% cold spot for the IM photon plan compared to 93%
for the proton plan), as the majority of the dose less than
90% occurs along this border region of the target volume.
For the proton plan, no such compromise has been made,
resulting in improved target coverage but consequently to an
increased dose to the rectal surface.
3.2.3. Case seven
This is a simulated case of a thyroid tumor, extending
down into the mediastinum to the level of the mid-lung.
The case was simulated on a rando phantom and VOIs for
the target, both lungs and spinal cord were de®ned from CT
slices taken of the phantom. The case was inspired by an
actual case that had occurred in a clinic outside of this
collaboration [13]. DVHs for all the de®ned VOIs are
shown in Fig. 7. The target DVHs for both photon plans is
clearly inferior to that of the proton plan, with substantial
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Fig. 5. DVHs for the PTV and all de®ned OARs for case 5.
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Fig. 6. Dose distributions for the IM photon (left image) and proton (right image) plan for case ®ve, zoomed in the area of the target rectum boundary. The
clearly reduced dosing to the rectal surface by the IM photon plan (between 60±80% of the target dose compared to 80±90% for the proton plan) has been
achieved at the cost of target dose homogeneity in the neighbourhood of the rectum when compared to the proton plan.
Fig. 7. DVHs for the PTV and all de®ned OARs for case 7.
compromising of the target dose indicated by the shallow
shoulder and slow increase to the 100% volume, particularly
for the IM photon plan. Again, this characteristic is re¯ected
in the quanti®cation provided in Table 2.
For the OARs, the proton plan also shows a clear advan-
tage in reducing the dose to the spinal cord (Fig. 7c). For mid
to low doses, protons also considerably reduce the dose to
both lungs. However, as seen in case 6 above, the crossing of
the IM photon DVHs curve at the 50% dose level indicates
improved high dose sparing by the use of IM photons. Again,
this characteristic of the two DVHs is re¯ected in differences
for the same OARs in Figs. 2 and 3 with all OARs being
below the zero line (proton advantage) for the mean dose
and the points for the two lung VOIs being above the zero
line (photon advantage) for the hot spot (Dsig) and V70 analy-
sis.
3.2.4. Case eight
The ®nal case is of a 45-year-old male presenting with an
acinus cell carcinoma of the right sub-lingual gland. The
tumour volume was relatively large (350 ccm) and partially
wrapped around the brain stem (see Fig. 1b). DVHs for the
target, non-target tissues and brain stem are shown in Fig. 8.
Only proton and intensity modulated photon plans were
performed for this case. The most signi®cant point of this
case is the large separation demonstrated between the brain
stem DVHs of the two plans. The IM photon plan demon-
strates superior sparing of this organ at almost all dose
levels, and particularly at the high (.50%) levels. Balanced
against this is a marked compromising of the dose to the
target volume, clearly seen in the target DVHs and quanti-
®ed somewhat in Table 2.
4. Discussion
In the previous sections we have presented the results of
treatment planning comparisons on nine separate cases,
covering a wide range of tumour types and sites. In this
presentation, we have aimed to summarise as well as possi-
ble the results of each of the plans, with the aim of providing
some quantitative information from which the reader can
draw conclusions as to the relative merits of standard
photon, intensity modulated photon and proton treatments.
Here we will discuss some points that can be concluded
from this work and provide pointers as to the role of the
different techniques and to their future development.
Over all the cases, it can be concluded that the proton
plans in general provided a better coverage of the target than
either of the standard or IM photon techniques (Table 2), in
addition to signi®cantly reducing mean doses to OARs and
the volumes of normal tissues and OARs irradiated to the 30
and 50% dose levels respectively (Table 3 and Fig. 3A,B).
At the 70% dose level however, little difference overall was
demonstrated between the volume of OARs irradiated by
the proton or IM photon plans, whilst the comparative
analysis of OAR hot spots (Dsig) showed a strong case and
OAR dependency (Fig. 2B). The data presented in Figs. 2
and 3 show quantitatively what is clear qualitatively in the
dose distributions of Fig. 1 that, the conformation of dose at
the 70% dose level and above is essentially the same for
both proton and intensity modulated photon plans, but that
the lower dose `wash' to surrounding tissues is considerably
reduced through the use of protons. In drawing conclusions
from these observations though, two important points
should be made.
Firstly, the clinical signi®cance of these results are a
matter of some debate. It is clear that for some critical struc-
tures, it is important to reduce the dose below prescribed
tolerance levels in order to reduce the possibility of side
effects, and it is clear that both photon IMRT and proton
therapy can reduce OAR doses, and therefore the risk of
complication, in comparison to the standard photon plans
used in this analysis. However, the relevance of high dose
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Fig. 8. DVHs for the PTV and all de®ned OARs for case 8.
sparing in comparison to reduction of the mid-to-low doses
depends heavily on the volume effect exhibited by each
OAR. For supposed serially organised organs (such as the
rectum in case 5), the comparable, and in some cases
improved, sparing of some OARs at and above the tolerance
dose in the IM photon plans compared to the corresponding
proton plans indicates that a comparable reduction in the
probability of complications to these types of organs is possi-
ble using both modalities. On the other hand, the mid-to-low
dose to large volumes of the lung in case 7, or to the intestine
in case 2 may restrict the effectiveness of IM photons in these
particular cases in comparison with protons. However, apart
from some well studied organs, such as the spinal cord and
lungs, the volume effect of organs is generally not well
known. A case in point is the rectum, which is generally
considered to be a serial organ (n  0:12 from Burman's
®tting of Emami's data [10,12, 29]), but which in recent
work has been suggested to be a parallel organ similar in
volume response to the lungs (n  0:9 [37]). If this latter
value were correct, then the reduced mean dose to the rectum
resulting from the proton plan in case 5 (Fig. 5) would in fact
be the more signi®cant factor clinically, rather than the
reduced high dose volume resulting from the IM photon
plan. Clearly then, without a more accurate knowledge of
the volume effect in such organs, it is very dif®cult to state
even a relative ranking of intersecting DVHs. An interesting
consequence of this uncertainty is that unless known other-
wise, it is as well to reduce medium as well as high doses in all
OARs as much as possible. As shown in this work, such a
goal can generally be better achieved through the use of
protons than through the use of either standard or IM photons.
In particular, case 2 shows signi®cantly reduced dose to all
OARs through the use of protons, perhaps suggesting that
large, irregularly shaped targets may be a particularly good
indication for this modality.
Secondly, it is necessary to determine which differences
are due to differences in radiation quality, and which are due
to differences in planning technologies. Take for example
case 8. The differences in dose to the brain stem between the
IM photon and proton plans are clearly signi®cant, but are in
all probability dependent not on the relative characteristics
of the radiation modality used, but on the relative sophisti-
cation of the planning methods applied. In all the cases
presented here, the proton plans have been calculated
using a small number (maximum 4, see Table 1) of essen-
tially homogenous ®elds (typically ^5±10% across each
®eld within the target volume), and in which no attempt
has been made to include individual critical organs (such
as the brain stem) into the optimisation process. In contrast,
for the IM photon approach, the dose from a large number of
different ®eld directions (nine in total) are calculated to be
in-homogenous, and are optimised using dose constraints
for both targets and critical structures. In this case, the abil-
ity to de®ne dose limits to organs at risk, coupled with the
additional degrees of freedom provided by intensity modu-
lation from multiple ®eld directions, allows the photon opti-
misation procedure to balance the dose between the target
and brain stem in a way that is not possible using the proton
planning techniques used in this work. A similar conclusion
can be reached for the rectum in case 5 (see Figs. 5 and 6).
Thus, one must be extremely cautious in concluding that
photons have an advantage over protons in these cases.
This is probably not an advantage of photons over protons,
but is more likely an advantage of inverse planning methods
over what can be considered to be the forward planning
methods used for the proton plans in this study.
In almost all cases presented here, protons provide an
advantage over IM photons by reducing both the mean
dose and V50 for all OARs, and it is likely that much of
this reduced mid-to-low dose component stems from the
advantageous physical characteristics of protons. However,
a word of caution is also justi®ed regarding this observation.
It is possible that through varying the parameters used in the
photon optimisations, some of the lower doses to particular
OARs could be further reduced. For instance, all IM photon
plans presented in this paper were performed using a dose
based optimisation based on the prescription of a single
tolerance dose for each OAR (see Table 4). As described
by Bortfeld [4], if a dose calculation point within an OAR
has a dose below this de®ned tolerance, then this point is
assigned a zero weight and plays no further role in the
optimisation (unless in subsequent iterations the dose is
raised above the tolerance dose once more). With such an
optimisation regime, it is clear that there is no bene®t to
reducing doses below the tolerance dose. Indeed, it is possi-
ble that the volume of an OAR receiving dose below toler-
ance is increased through the optimisation process. Such an
effect can be seen clearly in the DVHs for the bladder and
intestine in case 2 (Fig. 4). In each of these DVHs, the use of
IMRT reduces the high dose volume delivered to these
OARs in comparison to the standard photon plan, but
increases the lower dose volumes.
This observation is reinforced in the analysis of case 7
(Fig. 7). Here the standard photon plan reduces the low dose
volumes (,30% of the target dose) to the lungs more than
the IM photon plan. In many ways, this case is similar to a
test case discussed by Wang et al. for comparing the ef®cacy
of dose and biologically based optimisation criteria in the
calculation of intensity modulated ®elds [49]. In that work,
they found that when using a single tolerance dose optimi-
sation, little or no improvement could be gained over stan-
dard planning techniques in the region of the lung. The
results of this case reinforces this view somewhat. Wang
et al. then showed that the use of biologically based cost
functions had the ability to produce clinically more accep-
table plans. Consequently, it is possible that for this case in
particular, the use of alternative optimisation methods could
result in an improved IM photon plan. Indeed, by the addi-
tion of simple dose-volume constraints into the photon opti-
misation code used here, it has recently been shown that the
quality of plan in such circumstances can be much improved
[8].
A.J. Lomax et al. / Radiotherapy and Oncology 51 (1999) 257±271 269
A ®nal comment should be made concerning overall inte-
gral dose. It is clear from the results presented in Table 3
that the reduction of integral dose with protons is still signif-
icant, even compared to IMRT techniques (an average
reduction of just over two). Although it is true that the
clinical relevance of low doses to large volumes is largely
unknown (except perhaps in organs with a parallel or near
parallel architecture), there are cases where a reduction in
overall normal tissue dose may indeed be relevant. A typical
case is with paediatric patients, where it is clearly desirable
to reduce the dose load to normal tissue as much as possible.
However, other areas where integral dose could be impor-
tant are in repeat radiotherapy treatments or perhaps in
radiotherapy adjuvant to chemotherapy or surgery, in all
of which there is a need to preserve the viability of normal
tissues. Indeed, although the clinical relevance of integral
dose may be unknown in many cases, this does not neces-
sarily imply that integral dose is benign.
5. Conclusions
In this work, we have found that the use of protons in
radiotherapy could potentially provide both improved target
dose homogeneity and reduced mean and mid-to-low doses
to critical structures when compared to either standard or IM
photon treatments. Although the clinical advantage of redu-
cing such doses is not well understood in all cases, the use of
radiation modalities with superior dose localisation charac-
teristics to that of photons remain the only way of achieving
this goal and as such will inevitably play a role in the future
development of radiotherapy. At the 70% and above dose
levels, the ability to spare organs at risk has been shown to
be comparable for both IM photons and protons, and in three
of the nine cases studied, we have demonstrated that the use
of IM photons can provide signi®cant improved high dose
sparing in some critical structures. However, in each of
these cases we suggest that this improvement originates
from comparing inversely planned photons against forward
planned protons. For a true comparison, inverse techniques
must also be applied in proton therapy. Indeed, the 3D loca-
lisation of dose provided by the Bragg peak in principle
provides an additional degree of freedom in which intensity
can be modulated, and as such, may provide a method by
which highly conformal doses can be constructed even in
the most demanding of situations [28]. Consequently, a
detailed comparison of inverse methods for both photons
and protons is necessary to provide further insight into the
relative roles of these modalities in radiation oncology.
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